NCI Protocols

Return to Main
Clinical Research Page


Acute Lymphoblastic Leukemia  |  Acute Myeloid Leukemia  |  Brain Cancer - Pediatric Patients  |  Breast Cancer  |  Colon  |  Gastroesophageal  |  Glioblastoma  |  Head and Neck  |  Hepatoblastoma - Pediatric patients  |  Intermediate and Low Risk Hodgkin Disease - Pediatric patients  |  Leukemia  |  Localized Ependymoma  |  Lung, Tissue Repository  |  Lymphoma, Non-Hodgkin's  |  Lymphoma - Pediatric patients  |  Lymphoma, Specimen Repository  |  Melanoma  |  Methotrexate Toxicity  |  Multiple Myeloma  |  Neuroblastoma - Pediatric patients  |  Pancreatic  |  Prostate  |  Rectal  |  Renal  |  Renal Tumors - Pediatric Patients  |  Rhabdomyosarcoma  |  Safety Reporting of Erwinia L asparaginase  |  Sarcoma  |  Soft Tissue Sarcoma - Pediatric Patients


Acute Lymphoblastic Leukemia



Back to top


Acute Myeloid Leukemia



Back to top


Brain Cancer - Pediatric Patients



Back to top


Breast Cancer



Back to top


Colon



Back to top


Gastroesophageal



Back to top


Glioblastoma



Back to top


Head and Neck



Back to top


Hepatoblastoma - Pediatric patients



Back to top


Intermediate and Low Risk Hodgkin Disease - Pediatric patients



Back to top


Leukemia



Back to top


Localized Ependymoma



Back to top


Lung, Tissue Repository



Back to top


Lymphoma, Non-Hodgkin's



Back to top


Lymphoma - Pediatric patients



Back to top


Lymphoma, Specimen Repository



Back to top


Melanoma



Back to top


Methotrexate Toxicity



Back to top


Multiple Myeloma



Back to top


Neuroblastoma - Pediatric patients



Back to top


Pancreatic



Back to top


Prostate



Back to top


Rectal



Back to top


Renal



Back to top


Renal Tumors - Pediatric Patients



Back to top


Rhabdomyosarcoma



Back to top


Safety Reporting of Erwinia L asparaginase



Back to top


Sarcoma



Back to top


Soft Tissue Sarcoma - Pediatric Patients



Back to top